207. Integrated in silico evaluation of androstenediol derivative (monoxetanol) as a potential anticancer agent: insights from molecular docking, MD simulations, MM/PBSA, ADMET, and DFT analyses

Yahia Bekkar,1 Lanez Elhafnaoui, Nabeel A. Abdul-Rida, Wasfi A. Al-Masoudi, Ali M. Farhan,4 and Najim A. Al-Masoudi,✉
In Silico Pharmacology, 14, 134 (18 pages) 2026. https://doi.org/10.1007/s40203-026-00626-3
Publication year: 2026